Tharimmune, Inc. (THAR)
NASDAQ: THAR · Real-Time Price · USD
1.460
+0.090 (6.57%)
Mar 31, 2025, 1:40 PM EDT - Market open
Tharimmune Market Cap
Tharimmune has a market cap or net worth of $3.08 million as of March 31, 2025. Its market cap has decreased by -29.60% in one year.
Market Cap
3.08M
Enterprise Value
-586.02K
1-Year Change
-29.60%
Ranking
Category
Stock Price
$1.46
Market Cap Chart
Since the IPO on January 12, 2022, Tharimmune's market cap has decreased from $41.18M to $3.08M, a decrease of -92.52%. That is a compound annual growth rate of -55.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 2.97M | -24.26% |
| Dec 31, 2024 | 3.93M | 205.38% |
| Dec 29, 2023 | 1.29M | -71.40% |
| Dec 30, 2022 | 4.49M | -89.09% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |